Resource Library

Bringing a drug to market requires an extraordinary investment. In-house counsel at biotech and pharmaceutical companies routinely face the challenge of developing an IP strategy that maximizes an investment’s return. This is especially difficult when the market for approval of a drug is relatively small. This article provides an overview of the regulatory frameworks for orphan drugs in the United States and other developed and emerging markets.

Focused Assessments (audits) are an inherent risk when importing goods into the United States. Besides creating an effective compliance program, corporations should consider joining the C-TPAT and ISA programs to foster a more collaborative approach with CBP. Read this article to help prove your client is capable of self-auditing.

This is a sample non-compete agreement between a company and its executive.

Examines the guidance issued by the Office of Labor Management Standards and discusses the best practices for addressing LM-10 reporting obligations.

This is a sample sales agreement for a hotel room block commitment.

This is a sample sales agreement regarding hotel guest rooms, rates and revenue.

This is a sample agreement between a hotel and company.

This course explains our policy on giving business courtesies — gifts, meals and entertainment — to those with whom we do business, as well as our policy on accepting business courtesies. (Licensed for use in classroom settings only and not for distribution in any form.)

There are many actions that the other party may take during a negotiation that, whether inadvertent or intentional, can help delay or derail the process if you don't respond properly. Here is a second set of ten such scenarios, followed by some brief summary comments regarding how you may wish to respond in each instance.